These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1516520)

  • 21. Plasma proinsulin in patients with functioning pancreatic islet cell tumors.
    Sherman BM; Pek S; Fajans SS; Floyd JC; Conn JW
    J Clin Endocrinol Metab; 1972 Aug; 35(2):271-80. PubMed ID: 4342038
    [No Abstract]   [Full Text] [Related]  

  • 22. [Improved detection of insulinoma using perfusion-CT].
    Baumgartner K; Bitzer M; Overkamp D; Lauer U; Horger M
    Rofo; 2020 Aug; 192(8):721-724. PubMed ID: 31853907
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategy in the diagnosis of insulinoma.
    Faber OK; Kehlet H
    Scand J Gastroenterol Suppl; 1979; 53():45-8. PubMed ID: 225787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of immunoassays for insulin in diagnostic tests for insulinoma.
    Shimizu T; Sasakuma F; Ishikawa O; Matsumiya K; Hasegawa K; Sasaki A
    Diabetes Res Clin Pract; 1994 Dec; 26(2):149-54. PubMed ID: 7705197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of insulinoma diagnosed effectively by arterial stimulation and venous sampling using artificial islets of Langerhans].
    Osaki K; Hasama Y; Mimura K; Chijiiwa Y; Nakano I; Umeda F; Nawada A
    Nihon Naika Gakkai Zasshi; 1995 Jan; 84(1):130-1. PubMed ID: 7722357
    [No Abstract]   [Full Text] [Related]  

  • 26. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma proinsulin-like components.
    Gorden P; Roth J; Hendricks CM; Kahn CR
    Isr J Med Sci; 1974 Oct; 10(10):1212-21. PubMed ID: 4373413
    [No Abstract]   [Full Text] [Related]  

  • 28. Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.
    Deberg M; Houssa P; Frank BH; Sodoyez-Goffaux F; Sodoyez JC
    Clin Chem; 1998 Jul; 44(7):1504-13. PubMed ID: 9665430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.
    Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U
    J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma.
    Kao PC; Taylor RL; Service FJ
    J Clin Endocrinol Metab; 1994 May; 78(5):1048-51. PubMed ID: 8175958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
    Nauck MA; Meier JJ
    Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratic oscillatory characteristics of plasma insulin concentrations in patients with insulinoma: mechanism for unpredictable hypoglycemia.
    Berman N; Genter P; Chou HF; Cortez C; Bowsher R; Ipp E
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2899-903. PubMed ID: 9284716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained pulsatile insulin secretion from adenomatous human beta-cells. Synchronous cycling of insulin, C-peptide, and proinsulin.
    Chou HF; Ipp E; Bowsher RR; Berman N; Ezrin C; Griffiths S
    Diabetes; 1991 Nov; 40(11):1453-8. PubMed ID: 1936605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncated (des-[27-31]) C-peptide is not a major secretory product of human islets.
    Paoletta M; Kahn SE; Halban PA
    Diabetologia; 2002 Nov; 45(11):1523-7. PubMed ID: 12436335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?
    Porte D; Kahn SE
    Diabetes; 1989 Nov; 38(11):1333-6. PubMed ID: 2695369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycemic peripheral neuropathy in association with insulinoma: implication of glucopenia rather than hyperinsulinism. Case report and literature review.
    Jaspan JB; Wollman RL; Bernstein L; Rubenstein AH
    Medicine (Baltimore); 1982 Jan; 61(1):33-44. PubMed ID: 6276647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of plasma proinsulin analysis in the diagnosis of diabetes related diseases].
    Inoue Y; Kaneko T
    Nihon Rinsho; 1990 Dec; 48 Suppl():277-83. PubMed ID: 2086900
    [No Abstract]   [Full Text] [Related]  

  • 39. Abnormalities of proinsulin processing in functioning insulinomas: clinical implications.
    Wiesli P; Perren A; Saremaslani P; Pfammatter T; Spinas GA; Schmid C
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):424-30. PubMed ID: 15473873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic and clinical importance of proinsulin.
    Robbins DC; Tager HS; Rubenstein AH
    N Engl J Med; 1984 May; 310(18):1165-75. PubMed ID: 6369137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.